Asker Healthcare
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Market Cap & Net Worth: Asker Healthcare (ASKER)
Asker Healthcare (ST:ASKER) has a market capitalization of $2.21 Billion (Skr24.74 Billion) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #6318 globally and #35 in its home market, demonstrating a 1.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Asker Healthcare's stock price Skr64.58 by its total outstanding shares 383036497 (383.04 Million).
Asker Healthcare Market Cap History: 2025 to 2026
Asker Healthcare's market capitalization history from 2025 to 2026. Data shows growth from $2.88 Billion to $2.21 Billion (0.00% CAGR).
Asker Healthcare Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Asker Healthcare's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ASKER by Market Capitalization
Companies near Asker Healthcare in the global market cap rankings as of March 18, 2026.
Key companies related to Asker Healthcare by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Asker Healthcare Historical Marketcap From 2025 to 2026
Between 2025 and today, Asker Healthcare's market cap moved from $2.88 Billion to $ 2.21 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr2.21 Billion | -23.48% |
| 2025 | Skr2.88 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Asker Healthcare was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.21 Billion USD |
| MoneyControl | $2.21 Billion USD |
| MarketWatch | $2.21 Billion USD |
| marketcap.company | $2.21 Billion USD |
| Reuters | $2.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.